CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 2,050.00
+10.00 (0.49%)
At close: Feb 6, 2026
CMG Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Net Income | -9,592 | 2,695 | 6,455 | -388.14 | 3,051 | 6,065 |
Depreciation & Amortization | 3,231 | 3,346 | 2,558 | 2,284 | 2,106 | 1,846 |
Loss (Gain) From Sale of Assets | 0.8 | 11 | 4.09 | 22.76 | -0.5 | -2.58 |
Asset Writedown & Restructuring Costs | 1,133 | 1,133 | 241.97 | 329 | 91.25 | 114.1 |
Loss (Gain) From Sale of Investments | 5,792 | 5,909 | -35.58 | 4,145 | -534.01 | -612.06 |
Loss (Gain) on Equity Investments | 1,130 | 1,086 | -1,134 | 3,807 | - | - |
Stock-Based Compensation | 49.6 | 57.09 | 60.29 | 26.64 | 439.08 | 331.25 |
Provision & Write-off of Bad Debts | 1,229 | 468.43 | 10.6 | -219.54 | 213.58 | 373.24 |
Other Operating Activities | 911.96 | -5,046 | 3,436 | -764.94 | 2,545 | -825.32 |
Change in Accounts Receivable | -4,648 | -8,212 | -2,864 | -1,463 | -3,185 | -2,543 |
Change in Inventory | -14,335 | -4,677 | -497.72 | -8,857 | -939.47 | -1,147 |
Change in Accounts Payable | 2,385 | 2,816 | -2,049 | 6,207 | 165.71 | -2,840 |
Change in Other Net Operating Assets | 1,929 | 703.02 | -2,248 | -190.64 | -1,129 | 126.2 |
Operating Cash Flow | -10,784 | 290.09 | 3,938 | 4,938 | 2,823 | 886.78 |
Operating Cash Flow Growth | - | -92.63% | -20.24% | 74.88% | 218.39% | -54.48% |
Capital Expenditures | -24,769 | -28,098 | -12,384 | -8,382 | -8,176 | -2,546 |
Sale of Property, Plant & Equipment | 80.94 | - | 1.5 | - | 0.5 | 10.7 |
Cash Acquisitions | - | - | -3,129 | - | - | - |
Sale (Purchase) of Intangibles | -2,999 | -3,150 | -2,861 | -1,926 | -3,474 | -984.77 |
Investment in Securities | 57,990 | -2,616 | -16,834 | 3,485 | -58,948 | 12,358 |
Other Investing Activities | -125 | 164.73 | -45 | 49 | 1.9 | -59.35 |
Investing Cash Flow | 8,134 | -55,743 | -28,221 | -10,868 | -70,596 | 8,779 |
Long-Term Debt Issued | - | 56,785 | 21,500 | 6,000 | - | - |
Long-Term Debt Repaid | - | -294.31 | -404.51 | -371.85 | -113.56 | - |
Net Debt Issued (Repaid) | 3,038 | 56,491 | 21,095 | 5,628 | -113.56 | - |
Issuance of Common Stock | - | - | - | - | 72,992 | - |
Common Dividends Paid | - | - | -29.28 | - | - | - |
Other Financing Activities | -389.34 | 292.32 | -0 | -0 | - | - |
Financing Cash Flow | 2,649 | 56,783 | 21,066 | 5,628 | 72,878 | - |
Foreign Exchange Rate Adjustments | 15.22 | 15.12 | 3.07 | -0.94 | 0.44 | -0.57 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | 0 | - | -0 |
Net Cash Flow | 14.04 | 1,346 | -3,213 | -303.22 | 5,106 | 9,665 |
Free Cash Flow | -35,553 | -27,808 | -8,446 | -3,444 | -5,352 | -1,659 |
Free Cash Flow Margin | -35.41% | -28.06% | -8.99% | -4.19% | -9.13% | -3.33% |
Free Cash Flow Per Share | -249.96 | -176.98 | -60.81 | -24.80 | -44.03 | -15.24 |
Cash Interest Paid | 1,032 | 870.52 | 457.46 | 194.75 | - | - |
Cash Income Tax Paid | 385.89 | 41.22 | 687.44 | 107.61 | 183.95 | -51.15 |
Levered Free Cash Flow | -47,662 | -33,024 | 1,460 | - | -10,906 | -4,864 |
Unlevered Free Cash Flow | -45,113 | -31,454 | 1,509 | - | -10,900 | -4,864 |
Change in Working Capital | -14,670 | -9,370 | -7,658 | -4,304 | -5,087 | -6,403 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.